All Type of News
Psoriatic arthritis therapy ‘Guselkumab’ acquires approval in Korea
‘Guselkumab(product name: Tremfya Prefilled Syringe Inj),’ a Janssen’s psoriasis & arthritis therapy, acquired approval in Korea.
The Ministry of Food and Drug Safety(MFDS) decided new drug approval on ‘Tremfya Prefi...
Patient alliance concerning about suspension of Olital Tab development, demanding immediate actions
As patient advocates expressed concerns about suspension of the Olita Tab development, Hanmi Pharm, the Ministry of Food and Drug Safety(MFDS) and the Ministry of Health and Welfare(MOHW) insisted to prepare follow-up...
Chance to extend health insurance benefits for NICUs to PICUs
As part of short-term measures for safety control followed by the Ewha Womans University Mokdong Hospital incident, there is a high chance for health insurance benefits for dispensing drugs by hospital pharmacists to ...
Pharma distribution companies poor in operating profit last year
Pharmaceutical distribution companies reportedly had a low performance record in profitability, such as operating profits and net profits.
According to the analysis result of 2017 audit reports that 148 pharmaceutica...
19 pharmas distribution companies had total sales rate less than 5% last year
The sales cost rate that 19 pharmaceutical distribution companies had exceeded 95% last year. This means 12.8% of 149 studied companies had the figure.
Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports that 1...
MOHW starts substitute Olita for patients’ convenience
The Ministry of Health and Welfare(MOHW) decided to focus more on other drug substitutes over Olita whose development is terminated.
The MOHW expressed a stance about reviewing plans to terminate the development of H...
Chong Kun Dang exports biosimilar referencing anemia treatment to Japanese branch
Chong Kun Dang(CEO Young-Joo Kim) recently signed a business partnership agreement of ‘CKD-11101,’ a second-generation anemia treatment biosimilar, with a U.S. global pharmaceutical company’s Japanese branch. The agre...
Innovative pharmas gained 9% of sales with severe polarization
Last year, innovative pharmaceutical companies experienced an approximately 9% growth in sales, but reportedly had severe polarization in profitability.
Although general and foreign pharmaceutical companies had a gre...
No. of Korean pharmaceutical companies’ products rapidly decreases in the 20 most claimed products
In the top 20 most claimed products for the past 5 years, all the Korean products had reportedly lost the amount claimed.
According to the ‘Recent 5-Year Amount Claimed for Health Insurance Benefits’ published in the...
Top sales companies are Pfizer(KRW 751.6 billion), Novartis and Roche in order
Last year, Pfizer Pharmaceuticals Korea was ranked the top in sales among 17 overseas pharmaceutical companies.
Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports that 17 foreign pharmaceutical companies turne...
